Holen Sie sich die Stockscreener-App
1.29
0.00%
0.00
Handel nachbörslich:
1.29
Schlusskurs vom Vortag:
$1.29
Offen:
$1.28
24-Stunden-Volumen:
1.21M
Relative Volume:
0.71
Marktkapitalisierung:
$492.77M
Einnahmen:
$106.34M
Nettoeinkommen (Verlust:
$-74.66M
KGV:
-1.3579
EPS:
-0.95
Netto-Cashflow:
$-46.12M
1W Leistung:
+0.00%
1M Leistung:
-2.27%
6M Leistung:
+21.70%
1J Leistung:
-33.16%
1-Tages-Spanne:
$1.24
$1.30
1-Wochen-Bereich:
$1.20
$1.31
52-Wochen-Spanne:
$0.92
$2.32
Standard Biotools Inc Stock (LAB) Company Profile
Firmenname
Standard Biotools Inc
Sektor
Branche
Telefon
(650) 266-6000
Adresse
2 TOWER PLACE, SOUTH SAN FRANCISCO
Vergleichen Sie LAB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.29 | 473.67M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-13 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-02-27 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-04-16 | Eingeleitet | TD Cowen | Buy |
| 2024-04-04 | Eingeleitet | Jefferies | Buy |
| 2023-07-12 | Eingeleitet | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Aktie (LAB) Neueste Nachrichten
Is Standard BioTools Inc. likely to announce a buybackJuly 2025 Recap & AI Driven Stock Price Forecasts - khodrobank.com
Standard BioTools Inc. stock chart pattern explainedJuly 2025 Momentum & Fast Entry High Yield Stock Tips - Newser
Is a relief rally coming for Standard BioTools Inc. holders2025 EndofYear Setup & Free Expert Verified Stock Movement Alerts - Newser
Using AI based signals to follow Standard BioTools Inc.Market Activity Recap & Weekly Momentum Picks - Newser
Standard BioTools to consolidate R&D operations, announces $3.6 million in restructuring costs - Investing.com
Will Standard BioTools Inc. stock recover after recent dropShort Setup & Smart Money Movement Alerts - Newser
Standard BioTools Announces Strategic Restructuring Plan - TipRanks
Published on: 2025-09-03 04:31:17 - Newser
Applying Wyckoff theory to Standard BioTools Inc. stockJuly 2025 EndofMonth & Precise Entry and Exit Recommendations - Newser
How to monitor Standard BioTools Inc. with trend dashboardsMarket Performance Summary & Risk Controlled Swing Alerts - Newser
Standard BioTools Inc. stock daily chart insightsWeekly Gains Report & Weekly Return Optimization Alerts - Newser
Does Standard BioTools Inc. qualify in momentum factor screeningJuly 2025 Setups & Technical Pattern Based Buy Signals - Newser
Regression analysis insights on Standard BioTools Inc. performanceStop Loss & Weekly High Potential Stock Alerts - Newser
Has Standard BioTools Inc. formed a bullish divergenceCPI Data & Expert Approved Momentum Ideas - Newser
Is Standard BioTools Inc. stock reversal real or fakeWeekly Trade Analysis & Weekly High Conviction Ideas - Newser
Strategies to average down on Standard BioTools Inc.July 2025 Retail & Accurate Trade Setup Notifications - Newser
Ranking Standard BioTools Inc. among high performing stocks via toolsWeekly Profit Report & Verified Trade Idea Suggestions - Newser
Full technical analysis of Standard BioTools Inc. stockJuly 2025 EndofMonth & Safe Entry Trade Reports - Newser
Can a trend reversal in Standard BioTools Inc. lead to recovery2025 Analyst Calls & Weekly Watchlist of Top Performers - Newser
Sector ETF performance correlation with Standard BioTools Inc.Quarterly Trade Summary & AI Forecasted Entry and Exit Points - Newser
Key metrics from Standard BioTools Inc.’s quarterly dataJuly 2025 Pullbacks & Weekly High Conviction Trade Ideas - Newser
Analyzing recovery setups for Standard BioTools Inc. investorsJuly 2025 Movers & Weekly Chart Analysis and Guides - Newser
Is Standard BioTools Inc. vulnerable to short sellersTrade Ideas & Reliable Trade Execution Plans - khodrobank.com
Using Python tools to backtest Standard BioTools Inc. strategiesWall Street Watch & Verified Momentum Watchlists - Newser
What moving averages say about Standard BioTools Inc.Watch List & Fast Moving Stock Trade Plans - Newser
Detecting price anomalies in Standard BioTools Inc. with AIMarket Performance Summary & AI Forecasted Entry and Exit Points - Newser
Does Standard BioTools Inc. meet Warren Buffett’s criteria2025 Trade Ideas & Weekly Chart Analysis and Trade Guides - khodrobank.com
Is Standard BioTools Inc. stock forming a cup and handleJuly 2025 Snapshot & Low Risk High Win Rate Picks - khodrobank.com
What is Standard BioTools Inc.’s market positionPortfolio Value Summary & Verified Short-Term Plans - khodrobank.com
Will Standard BioTools Inc. face regulatory challengesJuly 2025 Earnings & Detailed Earnings Play Alerts - khodrobank.com
Is Standard BioTools Inc. still worth holding after the dipMarket Growth Review & High Conviction Investment Ideas - Newser
Comparing Standard BioTools Inc. in custom built stock radarsOil Prices & Accurate Technical Buy Alerts - Newser
Visualizing Standard BioTools Inc. stock with heatmapsJobs Report & Accurate Technical Buy Alerts - Newser
Price Reversal in Standard BioTools Inc. Traders Watch Closely getLinesFromResByArray error: size == 0 - thegnnews.com
Chart overlay techniques for tracking Standard BioTools Inc.2025 Biggest Moves & Safe Swing Trade Setups - Newser
Is Standard BioTools Inc. exposed to political risk2025 Trading Recap & Fast Entry High Yield Tips - sundaytimes.kr
Finanzdaten der Standard Biotools Inc-Aktie (LAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Standard Biotools Inc-Aktie (LAB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Casdin Partners Master Fund, L | Director |
Aug 25 '25 |
Buy |
1.24 |
200,000 |
248,180 |
60,150,000 |
| Casdin Partners Master Fund, L | Director |
Aug 26 '25 |
Buy |
1.26 |
125,000 |
157,938 |
60,275,000 |
| Casdin Partners Master Fund, L | Director |
Aug 15 '25 |
Buy |
1.22 |
150,000 |
183,210 |
59,750,000 |
| Casdin Partners Master Fund, L | Director |
Aug 14 '25 |
Buy |
1.21 |
133,220 |
161,543 |
59,600,000 |
| Casdin Partners Master Fund, L | Director |
Aug 13 '25 |
Buy |
1.31 |
75,000 |
98,280 |
59,466,780 |
| Kim Hanjoon Alex | Chief Financial Officer |
May 23 '25 |
Sale |
0.94 |
1,428 |
1,344 |
930,286 |
| Mackay Sean | SVP & Chief Business Officer |
May 23 '25 |
Sale |
0.94 |
13,217 |
12,437 |
843,076 |
| Egholm Michael | President & CEO |
May 23 '25 |
Sale |
0.94 |
5,473 |
5,150 |
2,741,191 |
| Kim Hanjoon Alex | Chief Financial Officer |
May 22 '25 |
Sale |
1.00 |
1,355 |
1,358 |
931,714 |
| Egholm Michael | President & CEO |
May 22 '25 |
Sale |
1.00 |
5,116 |
5,126 |
2,746,664 |
0.38%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):